BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12653107)

  • 1. Class V lupus nephritis: a clinicopathologic study in 152 patients.
    Chen Q; Liu Z; Hu W; Chen H; Zeng C; Li L
    J Nephrol; 2003; 16(1):126-32. PubMed ID: 12653107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
    Mitwalli AH; Hayat A; Alwakeel J; Hammad D
    Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.
    Hiramatsu N; Kuroiwa T; Ikeuchi H; Maeshima A; Kaneko Y; Hiromura K; Ueki K; Nojima Y
    Rheumatology (Oxford); 2008 May; 47(5):702-7. PubMed ID: 18390590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.
    Kim YG; Kim HW; Cho YM; Oh JS; Nah SS; Lee CK; Yoo B
    Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre.
    Vachvanichsanong P; Dissaneewate P; McNeil E
    Nephrol Dial Transplant; 2009 Sep; 24(9):2729-34. PubMed ID: 19395731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognosis and pathogenesis of severe lupus glomerulonephritis.
    Schwartz MM; Korbet SM; Lewis EJ;
    Nephrol Dial Transplant; 2008 Apr; 23(4):1298-306. PubMed ID: 18045825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study.
    Chrysochou C; Randhawa H; Reeve R; Waldek S; Wood GN; O'Donoghue DJ; Kalra PA
    QJM; 2008 Apr; 101(4):313-6. PubMed ID: 18270227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
    Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm followup of childhood lupus nephritis.
    Hagelberg S; Lee Y; Bargman J; Mah G; Schneider R; Laskin C; Eddy A; Gladman D; Urowitz M; Hebert D; Silverman E
    J Rheumatol; 2002 Dec; 29(12):2635-42. PubMed ID: 12465165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal variation of lupus nephritis: high prevalence of class V lupus nephritis during the winter and spring.
    Schlesinger N; Schlesinger M; Seshan SV
    J Rheumatol; 2005 Jun; 32(6):1053-7. PubMed ID: 15940767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis.
    do Nascimento AP; Viana Vdos S; Testagrossa Lde A; Leon EP; Borba EF; Barros RT; Bonfá E
    Arthritis Rheum; 2006 May; 54(5):1568-72. PubMed ID: 16645990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation and outcome in a cohort of paediatric patients with membranous lupus nephritis.
    Cramer CH; Mills M; Valentini RP; Smoyer WE; Haftel H; Brophy PD
    Nephrol Dial Transplant; 2007 Dec; 22(12):3495-500. PubMed ID: 17664180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus membranous nephropathy: long-term outcome.
    Pasquali S; Banfi G; Zucchelli A; Moroni G; Ponticelli C; Zucchelli P
    Clin Nephrol; 1993 Apr; 39(4):175-82. PubMed ID: 8491046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and prognosis of diffuse proliferative lupus nephritis with thrombotic microangiopathy.
    Hu WX; Liu ZZ; Chen HP; Zhang HT; Li LS; Liu ZH
    Lupus; 2010 Dec; 19(14):1591-8. PubMed ID: 20798137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-based differences in lupus nephritis: a study of 235 Indian patients.
    Soni SS; Gowrishankar S; Adikey GK; Raman A
    J Nephrol; 2008; 21(4):570-5. PubMed ID: 18651548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus membranous glomerulonephritis: different prognostic subgroups obscured by imprecise histologic classifications.
    Adler SG; Johnson K; Louie JS; Liebling MR; Cohen AH
    Mod Pathol; 1990 Mar; 3(2):186-91. PubMed ID: 2326250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal biopsy in lupus patients with low levels of proteinuria.
    Christopher-Stine L; Siedner M; Lin J; Haas M; Parekh H; Petri M; Fine DM
    J Rheumatol; 2007 Feb; 34(2):332-5. PubMed ID: 17183619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus nephritis in children in Malaysia.
    Khoo JJ; Pee S; Thevarajah B; Yap YC; Chin CK
    J Paediatr Child Health; 2005; 41(1-2):31-5. PubMed ID: 15670221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.